<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0041364" disease_type="Disease or Syndrome" abbrv="">tumor lysis syndrome</z:e> (ATLS) may be a dramatic complication of anticancer treatment </plain></SENT>
<SENT sid="1" pm="."><plain>It occurs mostly in <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">haematological malignancies</z:e> and less commonly in <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain><z:mp ids='MP_0002020'>Spontaneous tumor</z:mp> lysis syndrome (STLS) has been reported more frequently in Burkitt's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> than in other haematological <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, and exceptionally in <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> like small-cell <z:mp ids='MP_0008714'>lung carcinoma</z:mp> and <z:mpath ids='MPATH_310'>germ-cell tumors</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>We report on the case of a patient with a diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>) of the urinary tract involved by <z:hpo ids='HP_0001919'>acute renal failure</z:hpo> due to STLS and complicated by <z:mp ids='MP_0003587'>obstructive uropathy</z:mp> subsequent to neoplastic infiltration of the bladder </plain></SENT>
<SENT sid="4" pm="."><plain>Hyperhydration, urine alkalinization, urate oxidase administration and continuous veno-venous haemodiafiltration (CVVHDF) permitted to control the initial <z:hpo ids='HP_0000083'>renal failure</z:hpo> and to administer chemotherapy </plain></SENT>
<SENT sid="5" pm="."><plain>The patient then developed chemotherapy-induced <z:e sem="disease" ids="C0041364" disease_type="Disease or Syndrome" abbrv="">tumor lysis syndrome</z:e> (TLS) controlled by urate oxidase administration, hyperhydration and urine alkalinization </plain></SENT>
<SENT sid="6" pm="."><plain>The treatment of TLS and the differences between ATLS and STLS are discussed </plain></SENT>
</text></document>